{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:53:20Z","timestamp":1782269600058,"version":"3.54.5"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.pharmthera.2005.06.011","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T10:20:40Z","timestamp":1121768440000},"page":"86-93","source":"Crossref","is-referenced-by-count":34,"title":["The contribution of genetics to addiction therapy approaches"],"prefix":"10.1016","volume":"108","author":[{"given":"Howard J.","family":"Edenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2005.06.011_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0024-3205(80)90257-X","article-title":"Alterations of ethanol self-administration by naltrexone","volume":"26","author":"Altschuler","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300598","article-title":"Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden","volume":"30","author":"Bart","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib3","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1074\/jbc.M006352200","article-title":"A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling","volume":"276","author":"Befort","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00335-001-2074-2","article-title":"The replicability of QTLs for murine alcohol preference drinking behavior across eight independent studies","volume":"12","author":"Belknap","year":"2001","journal-title":"Mamm Genome"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"Mu opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2004.02340.x","article-title":"Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor","volume":"89","author":"Beyer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archpsyc.1981.01780340017001","article-title":"Maternal inheritance of alcohol abuse. Cross-fostering analysis of adopted women","volume":"38","author":"Bohman","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib8","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib10","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1523\/JNEUROSCI.17-10-03946.1997","article-title":"Quantitative trait loci involved in genetic predisposition to acute alcohol withdrawal in mice","volume":"17","author":"Buck","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib11","first-page":"8","article-title":"Molecular cloning and functional expression of a m-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/302540","article-title":"Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism","volume":"65","author":"Chen","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archpsyc.1981.01780330019001","article-title":"Inheritance of alcohol abuse. Cross-fostering analysis of adopted men","volume":"38","author":"Cloninger","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1530-0277.2003.tb02873.x","article-title":"Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods","volume":"27","author":"COMBINE Study Research Group","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archpsyc.1997.01830200024004","article-title":"Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial","volume":"54","author":"Cornelius","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.b.30091","article-title":"Allelic and haplotypic association of GABRA2 with alcohol dependence","volume":"129","author":"Covault","year":"2004","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib17","first-page":"273","article-title":"Review of naltrexone, a long-acting opiate antagonist","volume":"3","author":"Crabtree","year":"1984","journal-title":"Clin Pharm"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib18","first-page":"518","article-title":"Distribution of the \u03bc and \u03b4 opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats","volume":"275","author":"De Waele","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.011_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.ALC.0000108645.54345.98","article-title":"Association of GABRG3 with alcohol dependence","volume":"28","author":"Dick","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib21","first-page":"214","article-title":"The Collaborative study on the genetics of alcoholism: an update","volume":"26","author":"Edenberg","year":"2002","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/383283","article-title":"Variations in GABRA2, encoding the a2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations","volume":"74","author":"Edenberg","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib22","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajmg.b.30132","article-title":"Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence","volume":"133B","author":"Feinn","year":"2005","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1530-0277.2000.tb04634.x","article-title":"Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping","volume":"24","author":"Foroud","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1096-8628(20010108)105:1<114::AID-AJMG1074>3.0.CO;2-L","article-title":"Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence","volume":"105","author":"Franke","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF02244246","article-title":"Importance of delta opioid receptors in maintaining high alcohol drinking","volume":"103","author":"Froehlich","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jama.256.11.1449","article-title":"Disulfiram treatment of alcoholism. A Veterans Administration Cooperative study","volume":"256","author":"Fuller","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: a review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s004390050016","article-title":"Variant detection at the delta opioid receptor (OPRD1) locus and population genetics of a novel variant affecting protein sequence","volume":"107","author":"Gelernter","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.mp.4000556","article-title":"Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects","volume":"4","author":"Gelernter","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib31","first-page":"265","article-title":"Multiple opioid receptors: ligand selectivity profiles and binding signatures","volume":"36","author":"Goldstein","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib32","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1017\/S0033291797005643","article-title":"Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men","volume":"27","author":"Heath","year":"1997","journal-title":"Psychol Med"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.10054","article-title":"Association between the cortisol response to opioid blockade and alleles of the Asn40Asp polymorphism at the \u03bc-opioid receptor locus (OPRM1)","volume":"118B","author":"Hernandez-Avila","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib35","series-title":"Chapter in Pharmacogenomics: The Search for Individualized Therapies","first-page":"417","article-title":"The pharmacogenomics of alcoholism","author":"Hurley","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1176\/ajp.151.5.707","article-title":"A twin-family study of alcoholism in women","volume":"151","author":"Kendler","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02071128","article-title":"Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides","volume":"15","author":"Kieffer","year":"1995","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib37","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib39","doi-asserted-by":"crossref","first-page":"PL463","DOI":"10.1016\/0024-3205(94)90138-4","article-title":"Identification of a human delta opioid receptor: cloning and expression","volume":"54","author":"Knapp","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib40","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1530-0277.2001.tb02356.x","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02246191","article-title":"The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference","volume":"120","author":"Krishnan-Sarin","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ALC.0000158938.97464.90","article-title":"Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population","volume":"29","author":"Lappalainen","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm0495-337","article-title":"Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele","volume":"1","author":"Lawford","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15288\/jsa.2000.61.5","article-title":"Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking","volume":"61","author":"Li","year":"2000","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U","article-title":"Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from and autosome-wide scan in an American Indian population","volume":"81","author":"Long","year":"1998","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"issue":"1","key":"10.1016\/j.pharmthera.2005.06.011_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008571-200201000-00002","article-title":"The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine","volume":"12","author":"Lotsch","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.b.20034","article-title":"Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans","volume":"120","author":"Luo","year":"2003","journal-title":"Am J Med Genet Part B Neuropsychiatr Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-642-77460-7_5","article-title":"Anatomical distribution of opioid receptors in mammalians: an overview","volume":"104","author":"Mansour","year":"1993","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.7.2.92","article-title":"Confirmation of quantitative trait loci for ethanol sensitivity in long-sleep and short-sleep mice","volume":"7","author":"Markel","year":"1997","journal-title":"Genome Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the m-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1615\/CritRevNeurobiol.v12.i4.40","article-title":"Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents","volume":"12","author":"McBride","year":"1998","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1","volume":"23","author":"Neville","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib56","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the m-opioid receptor gene is associated with response to naltrexone treatment in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib57","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1360-0443.1989.tb00738.x","article-title":"Calcium carbimide in alcoholism treatment: Part 2. Medical findings of a short-term, placebo-controlled, double-blind clinical trial","volume":"84","author":"Peachey","year":"1989","journal-title":"Br J Addict"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib59","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.biopsych.2005.02.016","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders","volume":"57","author":"Petrakis","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/0-306-47939-7_18","article-title":"The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence","volume":"16","author":"Pettinati","year":"2003","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.1991.01810250021002","article-title":"Heterogeneity in the inheritance of alcoholism: a study of male and female twins","volume":"48","author":"Pickens","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib62","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/sj.npp.1300688","article-title":"GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated by finasteride","volume":"30","author":"Pierucci-Lagha","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2005.06.011_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.15288\/jsa.1998.59.631","article-title":"Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment","volume":"59","author":"Project MATCH Research Group","year":"1998","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib64","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/01.ALC.0000148114.34000.B9","article-title":"A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans","volume":"28","author":"Ray","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.0.CO;2-T","article-title":"Genome-wide search for genes affecting the risk for alcohol dependence","volume":"81","author":"Reich","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib66","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ, a neuropeptide that activates an opioid-like G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib67","first-page":"2108","article-title":"Human \u03bc-opioid receptor variation and alcohol dependence","author":"Sander","year":"1998","journal-title":"Alcohol Clin. Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib68","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.mp.4000951","article-title":"A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances","volume":"7","author":"Schinka","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.tpj.6500250","article-title":"The pharmacogenomics of selective serotonin reuptake inhibitors","volume":"4","author":"Serretti","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib70","first-page":"1015","article-title":"The human delta opioid receptor: genomic organization, cDNA cloning, functional expression and distribution in human brain","volume":"46","author":"Simonin","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib71","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1073\/pnas.92.15.7006","article-title":"Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system","volume":"92","author":"Simonin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0091-3057(82)90031-4","article-title":"A temporal analysis of naloxone's suppressant effect on drinking","volume":"16","author":"Siviy","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib73","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.94.4.1544","article-title":"Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia","volume":"94","author":"Sora","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib74","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/j.1471-4159.1990.tb04963.x","article-title":"The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study","volume":"55","author":"Spanagel","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib75","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib76","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<458::AID-AJMG3>3.0.CO;2-S","article-title":"Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency","volume":"88","author":"Town","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib77","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0165-6147(93)90068-U","article-title":"Delta-opioid receptor subtypes and cross-talk with mu-receptors","volume":"14","author":"Traynor","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.6539502","article-title":"Intragastric self-infusion of ethanol by ethanol-preferring and -nonpreferring lines of rats","volume":"225","author":"Waller","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(94)80368-4","article-title":"Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment","volume":"338","author":"Wang","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib81","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/hmg\/ddh194","article-title":"Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome","volume":"13","author":"Wang","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib82","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1530-0277.1999.tb04287.x","article-title":"Identification and confirmation of quantitative trait loci regulating alcohol consumption in congenic strains of mice","volume":"23","author":"Whatley","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib83","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/344287","article-title":"Alcohol dehydrogenase and alcohol dependence: variation in genotype-associated risk between populations","volume":"71","author":"Whitfield","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib84","series-title":"The World Health Report 2002: Reducing Risks, Promoting Healthy Life","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib85","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1006\/geno.1994.1117","article-title":"Localization of the kappa opioid receptor gene to human chromosome band 8q11.2","volume":"19","author":"Yasuda","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1355621961000124666","article-title":"The mu opioid receptor: from molecular cloning to functional studies","volume":"1","author":"Yu","year":"1996","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmthera.2005.06.011_bib87","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","article-title":"Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction","volume":"14","author":"Yuferov","year":"2004","journal-title":"Pharmacogenetics"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725805001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T23:30:19Z","timestamp":1551915019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725805001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0163725805001440"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2005.06.011","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}